In your words Massey, "spot on"!But, given the rising publicity...

In your words Massey, "spot on"!

But, given the rising publicity in this cell stem sphere, and the fact that it is a back door listing of Cynata, investors will be all over it upon relisting I think to establish long term positions.
Also, with the number of shares consolidated from 640m down to 57m post consolidation, the shares will be more tightly held i would imagine. Ditto the 17m options.

Last post for awhile.
GLAll.